Morgenthaler Venture Partners IX L.P., 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 340 shares at $13.00 ($4K) on 2016-10-31, disclosed to the SEC on 2016-10-31.
Open-market purchase of $4k RARX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.